Tlr2/4-Mediated Hyperinflammation Promotes Cherubism-Like Jawbone Expansion in Sh3bp2 (P416R) Knockin Mice

Yasuyuki Fujii, Nelson Monteiro, Shyam Kishor Sah, Homan Javaheri, Yasuyoshi Ueki, Zhichao Fan, Ernst J Reichenberger, I-Ping Chen, Yasuyuki Fujii, Nelson Monteiro, Shyam Kishor Sah, Homan Javaheri, Yasuyoshi Ueki, Zhichao Fan, Ernst J Reichenberger, I-Ping Chen

Abstract

Cherubism (CBM), characterized by expansile jawbones with multilocular fibrocystic lesions, is caused by gain-of-function mutations in SH3 domain-binding protein 2 (SH3BP2; mouse orthologue Sh3bp2). Loss of jawbone and dental integrity significantly decrease the quality of life for affected children. Treatment for CBM is limited to multiple surgeries to correct facial deformities. Despite significant advances made with CBM knockin (KI) mouse models (Sh3bp2 KI/KI ), the activation mechanisms of CBM lesions remain unknown because mutant mice do not spontaneously develop expansile jawbones. We hypothesize that bony inflammation of an unknown cause triggers jawbone expansion in CBM. To introduce jawbone inflammation in a spatiotemporally controlled manner, we exposed pulp of the first right mandibular molar of 6-week-old Sh3bp2 +/+ , Sh3bp2 KI/+ , and Sh3bp2 KI/KI mice. Bacterial invasion from the exposed pulp into root canals led to apical periodontitis in wild-type and mutant mice. The pathogen-associated molecular patterns (PAMPs)-induced inflammation of alveolar bone resulted in jawbone expansion in Sh3bp2 KI/+ and Sh3bp2 KI/KI mice. CBM-like lesions developed exacerbated inflammation with increased neutrophil, macrophage, and osteoclast numbers. These lesions displayed excessive neutrophil extracellular traps (NETs) compared to Sh3bp2 +/+ mice. Expression levels of IL-1β, IL-6, and TNF-α were increased in periapical lesions of Sh3bp2 +/+ , Sh3bp2 KI/+ , and Sh3bp2 KI/KI mice and also in plasma and the left untreated mandibles (with no pulp exposure) of Sh3bp2 KI/KI mice, suggesting a systemic upregulation. Ablation of Tlr2/4 signaling or depletion of neutrophils by Ly6G antibodies ameliorated jawbone expansion induced by PAMPs in Sh3bp2 KI/KI mice. In summary, successful induction of CBM-like lesions in jaws of CBM mice is important for studying initiating mechanisms of CBM and for testing potential therapies. Our findings further emphasize a critical role of host immunity in the development of apical periodontitis and the importance of maintaining oral health in CBM patients. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Keywords: CHERUBISM; GENETIC ANIMAL MODELS; JAW ABNORMALITIES; NEUTROPHIL EXTRACELLULAR TRAPS; OSTEOIMMUNOLOGY.

Conflict of interest statement

All authors declare that they have no conflicts of interest.

© 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Figures

Fig. 1
Fig. 1
CBM‐like jawbone expansion in Sh3bp2 mutant mice. (A) Timeline of mandible collection with or without pulp exposure of right 1st molar. Faxitron image confirmed the pulp access (yellow arrows). (B) Representative Faxitron images of expansile jawbones in Sh3bp2KI/+ and Sh3bp2KI/KI female mice. Yellow arrows indicate jawbone expansion. (C) Coronal planes and (D) axial planes of μCT images. Scale bar = 1 mm. (E) Quantification of jawbone dimensions by measuring distances from furcation of 1st molars to the top margin of incisors (FA′, FB′, FC′) and normalizing to distances from furcation to the end of root tips (FA, FB, FC) along lines A, B, and C. Data are presented as mean ± SD. Each dot in graphs represents a single biological sample (n = 5 per group). *p < 0.05, **p < 0.01 indicate statistical significance by two‐way ANOVA followed by Sidak correction. F = furcation.
Fig. 2
Fig. 2
Tlr2/4‐mediated inflammatory bone resorption is exacerbated in Sh3bp2KI/KI mice. Immunohistochemistry of paraffin‐embedded Sh3bp2KI/KI mandibular sections show (A) rapid infiltration (3 days after pulp exposure, middle panel) and interspersed influx (14 days after pulp exposure, right panel) of neutrophils stained with NIMPR14 antibody. Neutrophils in Sh3bp2+/+ mice were confined to the periapex of the roots. Scale bar = 500 μm. (B) Increased macrophages stained by CD68 antibody. Scale bar = 200 μm. (C) Increased bone resorption and multinucleated osteoclasts stained by CatK antibody. Scale bar = 500 μm (left) and 50 μm (right panel). (D) Quantification of macrophage numbers normalized to bone surface (mm2) and (E) CatK‐positive area normalized to bone perimeter (mm). n = 3–9 per group. (F) Coronal planes and (G) axial planes of μCT images from Sh3bp2+/+Tlr2/4KO/KO and Sh3bp2KI/KITlr2/4KO/KO mandibles with or without pulp exposure. (H) Quantitation of jawbone dimensions. No significant jawbone expansion 14 days after pulp exposure in Sh3bp2KI/KI mice when Tlr2/4 were knocked out although periapical lesions could still be observed. Data are presented as mean ± SD. Each dot in graphs represents a single biological sample (n = 4–5 per group). Measurements were analyzed using two‐way ANOVA followed by Sidak correction. *p < 0.05, **p < 0.01 indicate statistical significance. CatK = cathepsin K.
Fig. 3
Fig. 3
Increased local and systemic levels of inflammatory cytokines in Sh3bp2KI/KI mice after pulp exposure. qPCR showing gene expression of IL‐1β, IL‐6, and TNF‐α with or without pulp exposure (A) in treated right mandibles; (B) in left undrilled mandibles of Sh3bp2+/+, Sh3bp2KI/+, and Sh3bp2KI/KI experimental mice (n = 3–6 per group). (C) IL‐1β and IL‐6 plasma levels with or without pulp exposure in Sh3bp2+/+, Sh3bp2KI/+, and Sh3bp2KI/KI mice (n = 4–12 per group). No: naïve mice (no pulp exposure). Each dot in graphs represents a single biological sample. Data presented as mean ± SD. *p < 0.05, ** < 0.01 indicate significant difference by two‐way ANOVA followed by Sidak correction.
Fig. 4
Fig. 4
CBM mutation in Sh3bp2 enhances neutrophil‐mediated events that contribute to PAMPs‐induced jawbone expansion. (A) Increased SH3BP2 expression in sorted Ly6G‐positive cells from Sh3bp2KI/KI bone marrow shown by immunoblotting. (B) Increased percentages of blood neutrophils (Ly6G+CD115−) and monocytes (Ly6G−CD115+) in Sh3bp2KI/KI mice shown by flow cytometry (n = 5 per group). (C) Detection of MPO (green) and citrullinated H3 (pink) in Sh3bp2+/+ and Sh3bp2KI/KI right mandibles 14 days after pulp exposure. Scale bar = 200 μm. Histograms show quantification of MPO, citH3, and colocalization of MPO and citH3 signals normalized to DAPI (blue) from nine periapical and furcation areas in three Sh3bp2+/+ and Sh3bp2KI/KI mice. (D) Coronal and axial planes of μCT images of Sh3bp2KI/KI mice treated with Ly6G antibody or isotype control prior to and after pulp exposure. (E) Quantification of mandible expansion shows significant amelioration after Ly6G antibody treatment in Sh3bp2KI/KI mice compared to no antibody or isotype control (arrows) antibody. Scale bar = 1 mm. Each dot in graphs represents a single biological sample (n = 3–7 per group). Data are presented as mean ± SD. *p < 0.05, **p < 0.01 indicate significant difference by Student's t test (B), (C) and one‐way ANOVA (E).

References

    1. Jones WA. Cherubism. A thumbnail sketch of its diagnosis and a conservative method of treatment. Oral Surg Oral Med Oral Pathol. 1965;20(5):648‐653.
    1. Thompson N. Cherubism: familial fibrous dysplasia of the jaws. Br J Plast Surg. 1959;12:89‐103.
    1. Papadaki ME, Lietman SA, Levine MA, Olsen BR, Kaban LB, Reichenberger EJ. Cherubism: best clinical practice. Orphanet J Rare Dis. 2012;7(1):S6.
    1. Raposo‐Amaral CE, de Campos Guidi M, Warren SM, et al. Two‐stage surgical treatment of severe cherubism. Ann Plast Surg. 2007;58(6):645‐651.
    1. Reichenberger E, Tiziani V, Watanabe S, et al. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet. 2001;68(1326):1321‐1326.
    1. Ueki Y, Lin CY, Senoo M, et al. Increased myeloid cell responses to M‐CSF and RANKL cause bone loss and inflammation in SH3BP2 “cherubism” mice. Cell. 2007;128(1):71‐83.
    1. Guettler S, LaRose J, Petsalaki E, et al. Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease. Cell. 2011;147(6):1340‐1354.
    1. Levaot N, Voytyuk O, Dimitriou I, et al. Loss of Tankyrase‐mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. Cell. 2011;147(6):1324‐1339.
    1. Mukai T, Ishida S, Ishikawa R, et al. SH3BP2 Cherubism mutation potentiates TNF‐alpha‐induced osteoclastogenesis via NFATc1 and TNF‐alpha‐mediated inflammatory bone loss. J Bone Miner Res. 2014;29(12):2618‐2635.
    1. Yoshitaka T, Mukai T, Kittaka M, et al. Enhanced TLR‐MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism. Cell Rep. 2014;8(6):1752‐1766.
    1. Kakehashi S, Stanley HR, Fitzgerald RJ. The effects of surgical exposures of dental pulps in germ‐free and conventional laboratory rats. Oral Surg Oral Med Oral Pathol. 1965;20:340‐349.
    1. Torabinejad M, Eby WC, Naidorf IJ. Inflammatory and immunological aspects of the pathogenesis of human periapical lesions. J Endod. 1985;11(11):479‐488.
    1. Kawashima N, Stashenko P. Expression of bone‐resorptive and regulatory cytokines in murine periapical inflammation. Arch Oral Biol. 1999;44(1):55‐66.
    1. Prod'Homme V, Boyer L, Dubois N, et al. Cherubism allele heterozygosity amplifies microbe‐induced inflammatory responses in murine macrophages. J Clin Invest. 2015;125(4):1396‐1400.
    1. Southgate J, Sarma U, Townend JV, Barron J, Flanagan AM. Study of the cell biology and biochemistry of cherubism. J Clin Pathol. 1998;51(11):831‐837.
    1. Friedrich RE, Scheuer HA, Zustin J, Grob T. Cherubism: a case report with surgical intervention. Anticancer Res. 2016;36(6):3109‐3115.
    1. Chen G, Dimitriou I, Milne L, et al. The 3BP2 adapter protein is required for chemoattractant‐mediated neutrophil activation. J Immunol. 2012;189(5):2138‐2150.
    1. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532‐1535.
    1. Kessenbrock K, Krumbholz M, Schönermarck U, et al. Netting neutrophils in autoimmune small‐vessel vasculitis. Nat Med. 2009;15(6):623‐625.
    1. Kawai T, Akira S. The role of pattern‐recognition receptors in innate immunity: update on Toll‐like receptors. Nat Immunol. 2010;11(5):373‐384.
    1. Mukai T, Gallant R, Ishida S, et al. SH3BP2 gain‐of‐function mutation exacerbates inflammation and bone loss in a murine collagen‐induced arthritis model. PLoS One. 2014;9(8):e105518.
    1. Brinkmann V, Abu Abed U, Goosmann C, Zychlinsky A. Immunodetection of NETs in paraffin‐embedded tissue. Front Immunol. 2016;7:513.
    1. Coffelt SB, Kersten K, Doornebal CW, et al. IL‐17‐producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015;522(7556):345‐348.
    1. Conde P, Rodriguez M, van der Touw W, et al. DC‐SIGN(+) macrophages control the induction of transplantation tolerance. Immunity. 2015;42(6):1143‐1158.
    1. Finisguerra V, Di Conza G, di Matteo M, et al. MET is required for the recruitment of anti‐tumoural neutrophils. Nature. 2015;522(7556):349‐353.
    1. Moynihan KD, Opel CF, Szeto GL, et al. Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses. Nat Med. 2016;22(12):1402‐1410.
    1. Davis FM, Schaller MA, Dendekker A, et al. Sepsis induces prolonged epigenetic modifications in bone marrow and peripheral macrophages impairing inflammation and wound healing. Arterioscler Thromb Vasc Biol. 2019;39(11):2353‐2366.
    1. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol. 2008;8(4):279‐289.
    1. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826‐837.
    1. Chudler EH, Byers MR. Behavioural responses following tooth injury in rats. Arch Oral Biol. 2005;50(3):333‐340.
    1. Wayman JB. Cherubism: a report on three cases. Br J Oral Surg. 1978;16(1):47‐56.
    1. Motamedi MHK. Treatment of cherubism with locally aggressive behavior presenting in adulthood: report of four cases and a proposed new grading system. J Oral Maxillofac Surg. 1998;56(11):1336‐1342.
    1. Morice A, Joly A, Ricquebourg M, et al. Cherubism as a systemic skeletal disease: evidence from an aggressive case. BMC Musculoskelet Disord. 2020;21(1):564.
    1. Ahn MH, Han JH, Chwae YJ, et al. Neutrophil extracellular traps may contribute to the pathogenesis in adult‐onset still disease. J Rheumatol. 2019;46(12):1560‐1569.
    1. Kaplan MJ. Neutrophils in the pathogenesis and manifestations of SLE. Nat Rev Rheumatol. 2011;7(12):691‐699.
    1. Wright HL, Moots RJ, Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10(10):593‐601.
    1. Jackson Faircloth W, Edwards RC, Farhood VW. Cherubism involving a mother and daughter: case reports and review of the literature. J Oral Maxillofac Surg. 1991;49(5):535‐542.
    1. Özkan Y, Varol A, Turker N, Aksakalli N, Basa S. Clinical and radiological evaluation of cherubism: a sporadic case report and review of the literature. Int J Pediatr Otorhinolaryngol. 2003;67(9):1005‐1012.
    1. Meng XM, Yu SF, Yu GY. Clinicopathologic study of 24 cases of cherubism. Int J Oral Maxillofac Surg. 2005;34(4):350‐356.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi